Research Funders Make Secretive Overseas Investments: Report

An investigation by Science reveals that charities’ investments support activities opposed to their own missions, such as human health and environmental protection.

Written byAshley P. Taylor
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: The Cayman Islands sometimes serve as a tax haven.
© ISTOCK.COM, UNDEFINED

Many big-name research funders place millions of dollars in offshore investments, which in turn may drive activities that run contrary to the causes the charities promote, according to an investigative report published today (December 6) in Science.

The investigation covered the investments of seven of the world’s largest science funders. Of those, six charities—the Wellcome Trust, the Howard Hughes Medical Institute, the Robert Wood Johnson Foundation, the David and Lucile Packard Foundation, the Gordon and Betty Moore Foundation, and the William and Flora Hewlett Foundation—were found to have offshore investments that, combined, totaled at least $5 billion in recent years. The one charity that was not found to invest offshore is the Bill & Melinda Gates Foundation.

For his investigation, Charles Piller, a contributing correspondent for Science’s news department, relied on publicly available tax returns and financial statements ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies